Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus Nature Reviews Endocrinology Let me introduce you to a NEW peptide : Cagrilintide is an amylin analog which is now being developed in combination with GLP 1 agonist Semaglutide to achieve sustained Cagrisema 12mg Pre Filled Pen Fat freeze Does this chart seem accurate? : r cagrilintide Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Journal of Medicinal Chemistry